Table of Contents Author Guidelines Submit a Manuscript
Developmental Immunology
Volume 6, Issue 1-2, Pages 119-128
http://dx.doi.org/10.1155/1998/92198

Effector Mechanisms in Low-Dose Streptozotocin-induced Diabetes

1Immunology Unit, Faculty of Medicine, UAE University, P.O. Box 17666, Al Ain, United Arab Emirates
2Department of Microbiology and Immunology, Faculty of Medicine and Institute for Biological Research, University of Belgrade, Serbia

Accepted 30 May 1997

Copyright © 1998 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [93 citations]

The following is the list of published articles that have cited the current article.

  • Stosic-Grujicic, Dimitrijevic, and Bartlett, “Leflunomide protects mice from multiple low dose streptozotocin (MLD-SZ)-induced insulitis and diabetes,” Clinical and Experimental Immunology, vol. 117, no. 1, pp. 44–50, 1999. View at Publisher · View at Google Scholar
  • Frank Cloutier, and Réjean Couture, “ Pharmacological characterization of the cardiovascular responses elicited by kinin B 1 and B 2 receptor agonists in the spinal cord of streptozotocin-diabetic rats ,” British Journal of Pharmacology, vol. 130, no. 2, pp. 375–385, 2000. View at Publisher · View at Google Scholar
  • Som Nath Singh, Praveen Vats, Shoba Suri, Radhey Shyam, M.M.L Kumria, S Ranganathan, and K Sridharan, “Effect of an antidiabetic extract of Catharanthus roseus on enzymic activities in streptozotocin induced diabetic rats,” Journal of Ethnopharmacology, vol. 76, no. 3, pp. 269–277, 2001. View at Publisher · View at Google Scholar
  • Sandhya Sitasawad, Manisha Deshpande, Mamata Katdare, Suraj Tirth, and Pradeep Parab, “Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice (IDDM),” Diabetes Research and Clinical Practice, vol. 52, no. 2, pp. 77–84, 2001. View at Publisher · View at Google Scholar
  • Stanislava Stošic-Grujicic, Danijela Maksimovic, Vladimir Badovinac, Tatjana Samardžic, Vladimir Trajkovic, Miodrag Lukic, and Marija Mostarica Stojkovic, “Antidiabetogenic Effect of Pentoxifylline is Associated with Systemic and Target Tissue Modulation of Cytokines and Nitric Oxide Production,” Journal of Autoimmunity, vol. 16, no. 1, pp. 47–58, 2001. View at Publisher · View at Google Scholar
  • Réjean Couture, Madelaine Harrisson, Rose Mari Vianna, and Frank Cloutier, “Kinin receptors in pain and inflammation,” European Journal of Pharmacology, vol. 429, no. 1-3, pp. 161–176, 2001. View at Publisher · View at Google Scholar
  • D. Maksimovic-Ivanic, V. Trajkovic, Dj. Miljkovic, M. Mostarica Stojkovic, and S. Stosic-Grujicic, “Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil,” Clinical & Experimental Immunology, vol. 129, no. 2, pp. 214–223, 2002. View at Publisher · View at Google Scholar
  • E.P.K. Mensah-Brown, S. Stosic Grujicic, D. Maksimovic, A. Jasima, A. Shahin, and M.L. Lukic, “Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes,” Molecular Immunology, vol. 38, no. 12-13, pp. 941–946, 2002. View at Publisher · View at Google Scholar
  • A Hm Cardozo, D A Cabrini, M M Campos, G A Rae, J P Huidobro-Toro, and J B Calixto, “Diabetes-induced changes in responsiveness of rat bladder and vas deferens to peptides in vitro: susceptibility to reversal by insulin,” Canadian Journal of Physiology and Pharmacology, vol. 80, no. 4, pp. 334–340, 2002. View at Publisher · View at Google Scholar
  • Bichoy H Gabra, and Pierre Sirois, “Role of bradykinin B1 receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice,” European Journal of Pharmacology, vol. 457, no. 2-3, pp. 115–124, 2002. View at Publisher · View at Google Scholar
  • Takao Kobayashi, Qing-Hua Song, Tie Hong, Hajime Kitamura, and Jong-Chol Cyong, “Preventative effects of the flowers of Inula britannica on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin,” Phytotherapy Research, vol. 16, no. 4, pp. 377–382, 2002. View at Publisher · View at Google Scholar
  • B. Rachelle Merriman-Smith, Anatoly Krushinsky, Joerg Kistler, and Paul J. Donaldson, “Expression patterns for glucose transporters GLUT1 and GLUT3 in the normal rat lens and in models of diabetic cataract,” Investigative Ophthalmology and Visual Science, vol. 44, no. 8, pp. 3458–3466, 2003. View at Publisher · View at Google Scholar
  • Eun -Kyung Song, Hyeon Hur, and Myung -Kwan Han, “Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice,” Archives of Pharmacal Research, vol. 26, no. 7, pp. 559–563, 2003. View at Publisher · View at Google Scholar
  • Bichoy H Gabra, and Pierre Sirois, “Kinin B1 receptor antagonists inhibit diabetes-induced hyperalgesia in mice,” Neuropeptides, vol. 37, no. 1, pp. 36–44, 2003. View at Publisher · View at Google Scholar
  • Huafei Lu, Douglas Kraut, Louis C. Gerstenfeld, and Dana T. Graves, “Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation,” Endocrinology, vol. 144, no. 1, pp. 346–352, 2003. View at Publisher · View at Google Scholar
  • Muniappan Latha, and Leelavinothan Pari, “Preventive effects of Cassia auriculata L. flowers on brain lipid peroxidation in rats treated with stretozocin,” Molecular and Cellular Biochemistry, vol. 243, no. 1-2, pp. 23–28, 2003. View at Publisher · View at Google Scholar
  • Stanislava D. Stosic-Grujicic, Djordje M. Miljkovic, Ivana D. Cvetkovic, Danijela D. Maksimovic-Ivanic, and Vladimir Trajkovic, “Immunosuppressive and anti-inflammatory action of antioxidants in rat autoimmune diabetes,” Journal of Autoimmunity, vol. 22, no. 4, pp. 267–276, 2004. View at Publisher · View at Google Scholar
  • Stefan Nierkens, Leonie Nieuwenhuijsen, Mieke Thomas, and Raymond Pieters, “Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing a pontetial of drugs,” Toxicological Sciences, vol. 79, no. 1, pp. 90–97, 2004. View at Publisher · View at Google Scholar
  • Muniappan Latha, Leelavinothan Pari, Sandhya Sitasawad, and Ramesh Bhonde, “Scoparia dulcis, a traditional antidiabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo,” Journal of Biochemical and Molecular Toxicology, vol. 18, no. 5, pp. 261–272, 2004. View at Publisher · View at Google Scholar
  • Yan Li, Yan Gu, Ye Song, Li Zhang, Y. James Kang, Sumanth D. Prabhu, and Lu Cai, “Cardiac Functional Analysis by Electrocardiography, Echocardiography and in situ Hemodynamics in Streptozotocin-Induced Diabetic Mice,” Journal Of Health Science, vol. 50, no. 4, pp. 356–365, 2004. View at Publisher · View at Google Scholar
  • Shi-Jun Zheng, Salah-Eddine Lamhamedi-Cherradi, Pu Wang, Lingyun Xu, and Youhai H. Chen, “Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function,” Diabetes, vol. 54, no. 5, pp. 1423–1428, 2005. View at Publisher · View at Google Scholar
  • Liliana M Karabatas, Claudia Pastorale, Lidia Fabiano de Bruno, Fabricio Maschi, Omar H Pivetta, Yolanda B Lombardo, H??ctor Chemes, and Juan C Basabe, “Early Manifestations in Multiple-low-dose Streptozotocin-induced Diabetes in Mice,” Pancreas, vol. 30, no. 4, pp. 318–324, 2005. View at Publisher · View at Google Scholar
  • Miljkovic, Cvetkovic, Momcilovic, Maksimovic-Ivanic, Stosic-Grujicic, and Trajkovic, “Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells,” Cellular and Molecular Life Sciences, vol. 62, no. 22, pp. 2658–2668, 2005. View at Publisher · View at Google Scholar
  • Katakam, Chipitsyna, Gong, Vancha, Gabbeta, and Arafat, “Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): A novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production,” Journal of Endocrinology, vol. 187, no. 2, pp. 237–247, 2005. View at Publisher · View at Google Scholar
  • Chris F. Howarth, Qureshi, Shahin, and Lukic, “Effects of single high-dose and multiple low-dose streptozotocin on contraction and intracellular Ca2+ in ventricular myocytes from diabetes resistant and susceptible rats,” Molecular and Cellular Biochemistry, vol. 269, no. 1, pp. 103–108, 2005. View at Publisher · View at Google Scholar
  • Ayumi Fukuoka, Etsuko Fujii, Atsuhiko Kato, Hitoshi Arakawa, Yasuhiro Oda, Tsuneo Ito, Tetsuro Sugimoto, and Masami Suzuki, “Development of a Novel Model for Streptozotocin-induced Renal Cell Tumors and Chronic Diabetes in Göttingen Minipigs,” Journal of Toxicologic Pathology, vol. 18, no. 3, pp. 167–173, 2005. View at Publisher · View at Google Scholar
  • Nalamolu Koteswara Rao, and Srinivas Nammi, “Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats,” BMC Complementary and Alternative Medicine, vol. 6, 2006. View at Publisher · View at Google Scholar
  • Y. Suresh, and Undurti N. Das, “Differential effect of saturated, monounsaturated, and polyunsaturated fatty acids on alloxan-induced diabetes mellitus,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 74, no. 3, pp. 199–213, 2006. View at Publisher · View at Google Scholar
  • Eric P. K. Mensah-Brown, Allen Shahin, Mariam Al-Shamisi, Xiaoging Wei, and Miodrag L. Lukic, “IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin,” European Journal of Immunology, vol. 36, no. 1, pp. 216–223, 2006. View at Publisher · View at Google Scholar
  • P. Murugan, and L. Pari, “Effect of Tetrahydrocurcumin on Plasma Antioxidants in Streptozotocin-Nicotinamide Induced Experimental Diabetes,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 17, no. 4, 2006. View at Publisher · View at Google Scholar
  • Jianwei Zhou, Lingling Wang, Shucai Ling, and Xiaoming Zhang, “Expression changes of growth-associated protein-43 (GAP-43) and mitogen-activated protein kinase phosphatase-1 (MKP-1) and in hippocampus of streptozotocin-induced diabetic cognitive impairment rats,” Experimental Neurology, vol. 206, no. 2, pp. 201–208, 2007. View at Publisher · View at Google Scholar
  • T. Wang, K. Shankar, M. J. Ronis, and H. M. Mehendale, “Mechanisms and outcomes of drug- and toxicant-induced liver toxicity in diabetes,” Critical Reviews In Toxicology, vol. 37, no. 5, pp. 413–459, 2007. View at Publisher · View at Google Scholar
  • N Soltani, M Kumar, Y Glinka, G J Prud'Homme, and Q Wang, “In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes,” Gene Therapy, vol. 14, no. 12, pp. 981–988, 2007. View at Publisher · View at Google Scholar
  • Soleimani Safiyeh ., Fathiazar Baijani Fathallah ., Nejati Vahid ., Nazemiyeh Hossine ., and Shojaei Sadee Habib ., “Antidiabetic Effect of Equisetum arvense L. (Equisetaceae) in Streptozotocin-induced Diabetes in Male Rats,” Pakistan Journal of Biological Sciences, vol. 10, no. 10, pp. 1661–1666, 2007. View at Publisher · View at Google Scholar
  • Kyoung Ah Kang, Kyoung Hwa Lee, So Young Kim, Hee Sun Kim, Jin Sook Kim, and Jin Won Hyun, “Cytoprotective Effects of KIOM-79 on Streptozotocin Induced Cell Damage by Inhibiting ERK and AP-1,” Biological & Pharmaceutical Bulletin, vol. 30, no. 5, pp. 852–858, 2007. View at Publisher · View at Google Scholar
  • Sergiu Botolin, and Laura R. McCabe, “Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice,” Endocrinology, vol. 148, no. 1, pp. 198–205, 2007. View at Publisher · View at Google Scholar
  • S. Hässler, L. Peltonen, S. Sandler, and O. Winqvist, “Aire Deficiency Causes Increased Susceptibility to Streptozotocin-induced Murine Type 1 Diabetes,” Scandinavian Journal of Immunology, vol. 67, no. 6, pp. 569–580, 2008. View at Publisher · View at Google Scholar
  • Janice M. Zabolotny, Young-Bum Kim, Laura A. Welsh, Erin E. Kershaw, Benjamin G. Neel, and Barbara B. Kahn, “Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo,” Journal of Biological Chemistry, vol. 283, no. 21, pp. 14230–14241, 2008. View at Publisher · View at Google Scholar
  • Kyoung Ah Kang, Jin Sook Kim, and Jin Won Hyun, “KIOM-4 protects RINm5F pancreatic β-Cells against streptozotocin induced oxidative stress in vitro,” Biotechnology and Bioprocess Engineering, vol. 13, no. 2, pp. 150–157, 2008. View at Publisher · View at Google Scholar
  • Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne Van Etten, Annemieke Verstuyf, Hilary F. Luderer, Liesbet Lieben, Chantal Mathieu, and Marie Demay, “Vitamin D and human health: Lessons from vitamin D receptor null mice,” Endocrine Reviews, vol. 29, no. 6, pp. 726–776, 2008. View at Publisher · View at Google Scholar
  • Eun-Kyung Kim, Byung-Hyun Park, Mi-Young Song, In-Seob Kim, Woo Sung Moon, Do-Gon Ryu, Hong-Seob So, Raekil Park, Jin-Woo Park, and Kang-Beom Kwon, “Beneficial effect of Flos magnoliae extract on multiple low dose streptozotocin-induced type 1 diabetes development and cytokine-induced β-cell damage,” International Journal of Molecular Medicine, vol. 22, no. 4, pp. 481–488, 2008. View at Publisher · View at Google Scholar
  • Stanislava Stosic-Grujicic, Ivana Stojanovic, Danijela Maksimovic-Ivanic, Miljana Momcilovic, Dusan Popadic, Ljubica Harhaji, Djordje Miljkovic, Christine Metz, Katia Mangano, Gianpaolo Papaccio, Yousef Al-Abed, and Ferdinando Nicoletti, “Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus,” Journal of Cellular Physiology, vol. 215, no. 3, pp. 665–675, 2008. View at Publisher · View at Google Scholar
  • Maciej W. Ludwinski, Jing Sun, Brendan Hilliard, Shunyou Gong, Fan Xue, Ruaidhri J. Carmody, Jennifer DeVirgiliis, and Youhai H. Chen, “Critical roles of Bim in T cell activation and T cell–mediated autoimmune inflammation in mice,” Journal of Clinical Investigation, vol. 119, no. 6, pp. 1706–1713, 2009. View at Publisher · View at Google Scholar
  • Elodie Masson, Shlomit Koren, Fathima Razik, Howard Goldberg, Edwin P. Kwan, Laura Sheu, Herbert Y. Gaisano, and I. George Fantus, “High β-cell mass prevents streptozotocin-induced diabetes in thioredoxin-interacting protein-deficient mice,” American Journal of Physiology - Endocrinology and Metabolism, vol. 296, no. 6, pp. E1251–E1261, 2009. View at Publisher · View at Google Scholar
  • Jiang-Yan Yang, Jöel Walicki, Evrim Jaccard, Gilles Dubuis, Natasa Bulat, Jean-Pierre Hornung, Bernard Thorens, and Christian Widmann, “Expression of the NH2-terminal fragment of RasGAP in pancreatic β-cells increases their resistance to stresses and protects mice from diabetes,” Diabetes, vol. 58, no. 11, pp. 2596–2606, 2009. View at Publisher · View at Google Scholar
  • Masih-Ul Alam, Julie A. Harken, Anna-Maria Knorn, Alisha R. Elford, Kip Wigmore, Pamela S. Ohashi, and Douglas G. Millar, “Transgenic expression of Hsc70 in pancreatic islets enhances autoimmune diabetes in response to β cell damage,” Journal of Immunology, vol. 183, no. 9, pp. 5728–5737, 2009. View at Publisher · View at Google Scholar
  • M J Riedel, D F Gaddy, A Asadi, P D Robbins, and T J Kieffer, “DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes,” Gene Therapy, vol. 17, no. 2, pp. 171–180, 2009. View at Publisher · View at Google Scholar
  • Ming Xiang, Jing Tang, Xiao-Lei Zou, Zeng-Yu Zhao, Yun-Yang Wang, and Sheng-Nan Xie, “ β Cell Protecting and Immunomodulatory Activities of Paecilomyces Hepiali Chen Mycelium in STZ Induced T1DM Mice ,” The American Journal of Chinese Medicine, vol. 37, no. 02, pp. 361–372, 2009. View at Publisher · View at Google Scholar
  • E.P.K. Mensah-Brown, Z. Al Rabesi, A. Shahin, M. Al Shamsi, N. Arsenijevic, D.K. Hsu, F-T Liu, and M.L. Lukic, “Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice,” Clinical Immunology, vol. 130, no. 1, pp. 83–88, 2009. View at Publisher · View at Google Scholar
  • Osama M. Ahmed, and Gamal Allam, “The significance of vasoactive intestinal peptide in the treatment of Schistosoma mansoni-infected diabetic mice,” Asian Journal of Animal and Veterinary Advances, vol. 4, no. 4, pp. 172–190, 2009. View at Publisher · View at Google Scholar
  • Geum-Seon Lee, Ji-Young Choi, Yun-Jung Choi, Dong-Sool Yim, Tae-Jin Kang, and Jae-Hoon Cheong, “The Wound Healing Effect of Hydnocarpi Semen Extract on Ulcer in Diabetic Mice,” Biomolecules and Therapeutics, vol. 18, no. 3, pp. 329–335, 2010. View at Publisher · View at Google Scholar
  • Bernhard Maier, Takeshi Ogihara, Anthony P. Trace, Sarah A. Tersey, Reiesha D. Robbins, Swarup K. Chakrabarti, Craig S. Nunemaker, Natalie D. Stull, Catherine A. Taylor, John E. Thompson, Richard S. Dondero, Eli C. Lewis, Charles A. Dinarello, Jerry L. Nadler, and Raghavendra G. Mirmira, “The unique hypusine modification of eIF5A promotes islet β cell inflammation and dysfunction in mice,” Journal of Clinical Investigation, vol. 120, no. 6, pp. 2156–2170, 2010. View at Publisher · View at Google Scholar
  • Yong Bin Chen, Jing Li, Yuhong Qi, Xia Miao, Yongchun Zhou, Dongqing Ren, and G. Z. Guo, “The effects of electromagnetic pulses (EMP) on the bioactivity of insulin and a preliminary study of mechanism,” International Journal of Radiation Biology, vol. 86, no. 1, pp. 22–26, 2010. View at Publisher · View at Google Scholar
  • Ahmed M. Shehata, L. Quintanilla-Fend, Sabrina Bettio, C.B. Singh, and H.P.T. Ammon, “Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE),” Phytomedicine, vol. 18, no. 12, pp. 1037–1044, 2011. View at Publisher · View at Google Scholar
  • M.B. Patel, and S.H. Mishra, “ Hypoglycemic activity of C-glycosyl flavonoid from Enicostemma hyssopifolium ,” Pharmaceutical Biology, vol. 49, no. 4, pp. 383–391, 2011. View at Publisher · View at Google Scholar
  • Eric P. Mensah-Brown, Allen Shahin, Mariam Al Shamisi, and Miodrag L. Lukic, “Early influx of macrophages determines susceptibility to experimental allergic encephalomyelitis in Dark Agouti (DA) rats,” Journal of Neuroimmunology, vol. 232, no. 1-2, pp. 68–74, 2011. View at Publisher · View at Google Scholar
  • Kwang Bon, Hyung Joo Suh, Kyung Soo Ra, and Jang Won Choi, “Protective effect of cyclo(His-Pro) on streptozotocin-induced cytotoxicity and apoptosis in vitro,” Journal of Microbiology and Biotechnology, vol. 21, no. 2, pp. 218–227, 2011. View at Publisher · View at Google Scholar
  • Chien-Ming Hu, Joe-Sharg Li, Khoot-Peng Cheah, Che-Wei Lin, Wen-Yu Yu, Ming-Long Chang, Geng-Chang Yeh, Sheng-Hsuan Chen, Hui-Wen Cheng, and Cheuk-Sing Choy, “Effect of Sanguis draconis (a dragon's blood resin) on streptozotocin- and cytokine-induced β-cell damage, in vitro and in vivo,” Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 417–425, 2011. View at Publisher · View at Google Scholar
  • Tamara Saksida, Miljković, Dragana Dekanski, Ivana Stojanović, and Stanislava Stošić-Grujičić, “Dry olive leaf extract (DOLE) down-regulates the progression of experimental immune-mediated diabetes by modulation of cytokine profile in the draining lymph nodes,” Archives of Biological Sciences, vol. 63, no. 2, pp. 289–297, 2011. View at Publisher · View at Google Scholar
  • Anthony Jide Afolayan, and Taofik Olatunde Sunmonu, “Artemisia afra Jacq. Ameliorates Oxidative Stress in the Pancreas of Streptozotocin-Induced Diabetic Wistar Rats,” Bioscience, Biotechnology, and Biochemistry, vol. 75, no. 11, pp. 2083–2086, 2011. View at Publisher · View at Google Scholar
  • Juane Li, Tonghua Liu, Lei Wang, Xiangyu Guo, Tunhai Xu, Lili Wu, Lingling Qin, and Wen Sun, “Antihyperglycemic and antihyperlipidemic action of cinnamaldehyde in C57blks/j Db/db mice,” Journal of Traditional Chinese Medicine, vol. 32, no. 3, pp. 446–452, 2012. View at Publisher · View at Google Scholar
  • Aileen JF King, “The use of animal models in diabetes research,” British Journal of Pharmacology, vol. 166, no. 3, pp. 877–894, 2012. View at Publisher · View at Google Scholar
  • Young Joo Hong, Nayoung Kim, Karim Lee, Chung Hee Sonn, Jung Eun Lee, Sung Tae Kim, In Ho Baeg, and Kyung-Mi Lee, “Korean red ginseng (Panax ginseng) ameliorates type 1 diabetes and restores immune cell compartments,” Journal of Ethnopharmacology, vol. 144, no. 2, pp. 225–233, 2012. View at Publisher · View at Google Scholar
  • Marisa M. Fisher, Cristina N. Perez Chumbiauca, Kieren J. Mather, Raghavendra G. Mirmira, and Sarah A. Tersey, “Detection of Islet beta-Cell Death in Vivo by Multiplex PCR Analysis of Differentially Methylated DNA,” Endocrinology, vol. 154, no. 9, pp. 3476–3481, 2013. View at Publisher · View at Google Scholar
  • L. C. da Rosa, F. Chiuso-Minicucci, S. F. G. Zorzella-Pezavento, T. G. D. França, L. L. W. Ishikawa, P. M. Colavite, B. Balbino, L. C. B. Tavares, C. L. Silva, C. Marques, M. R. V. Ikoma, and A. Sartori, “Bacille Calmette-Guérin/DNAhsp65 prime-boost is protective against diabetes in non-obese diabetic mice but not in the streptozotocin model of type 1 diabetes,” Clinical & Experimental Immunology, vol. 173, no. 3, pp. 430–437, 2013. View at Publisher · View at Google Scholar
  • Sarah A. Tersey, Stephanie C. Colvin, Bernhard Maier, and Raghavendra G. Mirmira, “Protective effects of polyamine depletion in mouse models of type 1 diabetes: implications for therapy,” Amino Acids, 2013. View at Publisher · View at Google Scholar
  • Mariam Al Shamsi, Allen Shahin, Yoichiro Iwakura, Miodrag L. Lukic, and Eric P.K. Mensah-Brown, “Pam3CSK4 enhanced beta cell loss and diabetogenesis: The roles of IFN- gamma and IL-17,” Clinical Immunology, 2013. View at Publisher · View at Google Scholar
  • Jung-Ran Noh, Jung Hwan Hwang, Yong-Hoon Kim, Kyoung-Shim Kim, Gil-Tae Gang, Sang-Woo Kim, Don-Kyu Kim, Minho Shong, In-Kyu Lee, Hueng-Sik Choi, and Chul-Ho Lee, “The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice,” The International Journal of Biochemistry & Cell Biology, 2013. View at Publisher · View at Google Scholar
  • Undurti N. Das, “Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 88, no. 3, pp. 201–210, 2013. View at Publisher · View at Google Scholar
  • Nancy Ho, Bethany R. Brookshire, Janet E. Clark, and Irwin Lucki, “Indomethacin reverses decreased hippocampal cell proliferation in streptozotocin-induced diabetic mice,” Metabolic Brain Disease, 2014. View at Publisher · View at Google Scholar
  • Ivana Nikolic, Tamara Saksida, Katia Mangano, Milica Vujicic, Ivana Stojanovic, Ferdinando Nicoletti, and Stanislava Stosic-Grujicic, “Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects,” Diabetologia, 2014. View at Publisher · View at Google Scholar
  • S. Vasu, R. C. Moffett, N. H. McClenaghan, and P. R. Flatt, “Responses of GLP1-secreting L-cells to cytotoxicity resemble pancreatic  -cells but not  -cells,” Journal of Molecular Endocrinology, vol. 54, no. 1, pp. 91–104, 2014. View at Publisher · View at Google Scholar
  • I. B. Sukhov, V. N. Shipilov, O. V. Chistyakova, A. M. Trost, and A. O. Shpakov, “Long-term intranasal insulin administration improves spatial memory in male rats with prolonged type 1 diabetes mellitus and in healthy rats,” Doklady Biological Sciences, vol. 453, no. 1, pp. 349–352, 2014. View at Publisher · View at Google Scholar
  • Sarah A. Tersey, Esther Bolanis, Theodore R. Holman, David J. Maloney, Jerry L. Nadler, and Raghavendra G. Mirmira, “Minireview: 12-lipoxygenase and islet β-cell dysfunction in diabetes,” Molecular Endocrinology, vol. 29, no. 6, pp. 791–800, 2015. View at Publisher · View at Google Scholar
  • Ui-Jin Bae, Hyun-Young Jang, Jung Min Lim, Li Hua, Jae-Ha Ryu, and Byung-Hyun Park, “Polyphenols isolated from Broussonetia kazinoki prevent cytokine-induced β-cell damage and the development of type 1 diabetes,” Experimental & Molecular Medicine, vol. 47, no. 4, pp. e160, 2015. View at Publisher · View at Google Scholar
  • Brent D. Volper, Richard T. Huynh, Kathryn A. Arthur, Joshua Noone, Benjamin D. Gordon, Emily W. Zacherle, Eduardo Munoz, Mikkel A. Sorensen, Rene B. Svensson, Tom L. Broderick, S. Peter Magnusson, Reuben Howden, Taben M. Hale, and Chad C. Carroll, “Influence of acute and chronic streptozotocin-induced diabetes on the rat tendon extracellular matrix and mechanical properties,” American Journal Of Physiology-Regulatory Integrative And Comparative Physiology, vol. 309, no. 9, pp. R1135–R1143, 2015. View at Publisher · View at Google Scholar
  • Aileen King, and James Bowe, “Animal models for diabetes: Understanding the pathogenesis and finding new treatments,” Biochemical Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Dyah Ratna Wulan, Edi Priyo Utomo, and Chanif Mahdi, “ Antidiabetic Activity of Ruellia tuberosa L., Role of α -Amylase Inhibitor: In Silico , In Vitro , and In Vivo Approaches ,” Biochemistry Research International, vol. 2015, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Bingdong Sui, Chenghu Hu, Li Liao, Yichen Chen, Xinyi Zhang, Xin Fu, Chenxi Zheng, Meng Li, Ling Wu, Xinyi Zhao, and Yan Jin, “Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesis,” Scientific Reports, vol. 6, pp. 30186, 2016. View at Publisher · View at Google Scholar
  • Zhanchun Li, Lijun Zhao, Stellan Sandler, and F. Anders Karlsson, “Expression of Pancreatic Islet MHC Class I, Insulin, and ICA 512 Tyrosine Phosphatase in Low-dose Streptozotocin-induced Diabetes in Mice,” Journal of Histochemistry & Cytochemistry, vol. 48, no. 6, pp. 761–767, 2016. View at Publisher · View at Google Scholar
  • Allison L. Brill, Jaclyn A. Wisinski, Mark T. Cadena, Mary F. Thompson, Rachel J. Fenske, Harpreet K. Brar, Michael D. Schaid, Renee L. Pasker, and Michelle E. Kimple, “Synergy Between G alpha(z) Deficiency and GLP-1 Analog Treatment in Preserving Functional beta-Cell Mass in Experimental Diabetes,” Molecular Endocrinology, vol. 30, no. 5, pp. 543–556, 2016. View at Publisher · View at Google Scholar
  • Naveen KV. Gundala, Vegi G.M. Naidu, and Undurti N. Das, “Arachidonic acid (AA) and lipoxin A4 (LXA4) attenuate streptozotocin-induced cytotoxicity to RIN5F cells in vitro and type 1 and type 2 diabetes mellitus in vivo,” Nutrition, 2016. View at Publisher · View at Google Scholar
  • Yuriko Itzel Sánchez-Zamora, Imelda Juarez-Avelar, Alicia Vazquez-Mendoza, Marcia Hiriart, and Miriam Rodriguez-Sosa, “ Altered Macrophage and Dendritic Cell Response in Mif −/− Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes ,” Journal of Diabetes Research, vol. 2016, pp. 1–19, 2016. View at Publisher · View at Google Scholar
  • Marimar Hernandez-Perez, Gaurav Chopra, Jonathan Fine, Abass M. Conteh, Ryan M. Anderson, Amelia K. Linnemann, Chanelle Benjamin, Jennifer B. Nelson, Kara S. Benninger, Jerry L. Nadler, David J. Maloney, Sarah A. Tersey, and Raghavendra G. Mirmira, “Inhibition of 12/15-Lipoxygenase Protects Against β-Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes,” Diabetes, vol. 66, no. 11, pp. 2875–2887, 2017. View at Publisher · View at Google Scholar
  • Undurti N. Das, “Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?,” Frontiers in Endocrinology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Adam L. Burrack, Tijana Martinov, and Brian T. Fife, “T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes,” Frontiers in Endocrinology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Michela Novelli, Pascale Beffy, Alex Gregorelli, Svetlana Porozov, Fabrizio Mascia, Chiara Vantaggiato, Pellegrino Masiello, and Marta Menegazzi, “Persistence of STAT-1 inhibition and induction of cytokine resistance in pancreatic β cells treated with St John's wort and its component hyperforin,” Journal of Pharmacy and Pharmacology, 2017. View at Publisher · View at Google Scholar
  • Nowsheen Goonoo, and Archana Bhaw-Luximon, “Analyzing polymeric nano fibrous scaffold performances in diabetic animal models for translational chronic wound healing research,” Nanotechnology Reviews, no. 0, 2017. View at Publisher · View at Google Scholar
  • Shivam H. Patel, Arman Sabbaghi, and Chad C. Carroll, “Streptozotocin-induced diabetes alters transcription of multiple genes necessary for extracellular matrix remodeling in rat patellar tendon,” Connective Tissue Research, pp. 1–11, 2018. View at Publisher · View at Google Scholar
  • Pin-Chun Chao, Yingxiao Li, Chin-Hong Chang, Ja Ping Shieh, Juei-Tang Cheng, and Kai-Chun Cheng, “Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes,” Biomedicine & Pharmacotherapy, vol. 101, pp. 155–161, 2018. View at Publisher · View at Google Scholar
  • Ivana Bjelobaba, Vesna Begovic-Kupresanin, Sanja Pekovic, and Irena Lavrnja, “Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis,” Journal of Neuroscience Research, 2018. View at Publisher · View at Google Scholar
  • Revathy Jayaraman, Srinivasan Subramani, Shahul Hameed Sheik Abdullah, and Muruganathan Udaiyar, “Antihyperglycemic effect of hesperetin, a citrus flavonoid, extenuates hyperglycemia and exploring the potential role in antioxidant and antihyperlipidemic in streptozotocin-induced diabetic rats,” Biomedicine & Pharmacotherapy, vol. 97, pp. 98–106, 2018. View at Publisher · View at Google Scholar
  • Undurti N. Das, “Arachidonic acid in health and disease with focus on hypertension and diabetes mellitus,” Journal of Advanced Research, 2018. View at Publisher · View at Google Scholar